| Date Filed |
Document No. |
Description |
Snippet |
Link To Document |
| 2013-02-20 |
1 |
|
. 7,932,241 (“the ‘241 patent”) directed to certain approved presentations for
zoledronic acid.
5. Upon…Novartis’ patent rights can be
enforced
4. The three patents awarded to Novartis by the U.S. Patent and Trademark…are:
U.S. Patent No. 8,324,189 (“the ‘189 patent”) directed to oncology methods, U.S. Patent No.
8,052,987…ACTION
2. This is an action for patent infringement under the patent laws of the United States,
Title…987 patent”) directed to methods for treating abnormally increased bone turnover,
and U.S. Patent No. |
External link to document |
| 2013-03-27 |
146 |
Exhibit 2 |
one Pozen patent (U.S. Patent 6,926,907—“the ‘907 patent”) and five
AstraZeneca patents (not at issue… responses with regard to the ‘907 patent only. The
‘907 patent has 55 claims. On November 17, 2011…907 patent. Subsequently, Plaintiffs
further narrowed their asserted claims of the ‘907 patent to …VIMOVO® drug prior to the expiration of Plaintiffs’ patents. Id.
DRL is the first ANDA filer for…dkt. nos. 41 and 82.
A. The ‘907 Patent
Plaintiffs seek leave to amend their |
External link to document |
| 2013-04-30 |
225 |
|
primarily on the assertion of U.S. Patent No. 7,932,241 (“the ’241 patent”) in both the
2012 Case and …U.S. Patent No. 8,052,987 (“the ’987 patent”)
and U.S. Patent No. 8,324,189 (“the ’189 patent”), which…and the February 2013 Case. The ’241 patent is the only patent from which Novartis
asserted claims in…which are method of use patents asserted in
the 2013 Cases, the ’241 patent is directed to the packaging…to improperly skirt the Local Patent Rules and revive the ’987
patent in the 2012 Case. Wockhardt is |
External link to document |
| Date Filed |
Document No. |
Description |
Snippet |
Link To Document |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
